SARS-CoV-2 Vaccines: Status Report

SARS-CoV-2, the causal agent of COVID-19, first emerged in late 2019 in China. It has since infected more than 870,000 individuals and caused more than 43,000 deaths globally. Here, we discuss therapeutic and prophylactic interventions for SARS-CoV-2 with a focus on vaccine development and its chall...

Descripción completa

Detalles Bibliográficos
Autores principales: Amanat, Fatima, Krammer, Florian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7136867/
https://www.ncbi.nlm.nih.gov/pubmed/32259480
http://dx.doi.org/10.1016/j.immuni.2020.03.007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7136867/
https://www.ncbi.nlm.nih.gov/pubmed/32259480
http://dx.doi.org/10.1016/j.immuni.2020.03.007

Ejemplares similares